A detailed history of M&R Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, M&R Capital Management Inc holds 1,802 shares of LLY stock, worth $1.38 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
1,802
Previous 1,758 2.5%
Holding current value
$1.38 Million
Previous $1.59 Million 0.31%
% of portfolio
0.36%
Previous 0.39%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

BUY
$772.14 - $960.02 $33,974 - $42,240
44 Added 2.5%
1,802 $1.6 Million
Q2 2024

Jul 02, 2024

SELL
$724.87 - $909.04 $10,148 - $12,726
-14 Reduced 0.79%
1,758 $1.59 Million
Q1 2024

Apr 02, 2024

SELL
$592.2 - $792.28 $358,281 - $479,329
-605 Reduced 25.45%
1,772 $1.38 Million
Q4 2023

Jan 02, 2024

BUY
$525.19 - $619.13 $12,604 - $14,859
24 Added 1.02%
2,377 $1.39 Million
Q3 2023

Oct 10, 2023

SELL
$434.7 - $599.3 $46,512 - $64,125
-107 Reduced 4.35%
2,353 $1.26 Million
Q2 2023

Jul 05, 2023

BUY
$350.74 - $468.98 $350 - $468
1 Added 0.04%
2,460 $1.15 Million
Q1 2023

Apr 03, 2023

SELL
$310.63 - $364.82 $70,202 - $82,449
-226 Reduced 8.42%
2,459 $844,000
Q4 2022

Jan 11, 2023

BUY
$321.55 - $374.67 $130,549 - $152,116
406 Added 17.81%
2,685 $0
Q3 2022

Oct 03, 2022

SELL
$296.48 - $337.87 $13,341 - $15,204
-45 Reduced 1.94%
2,279 $737,000
Q2 2022

Jul 05, 2022

BUY
$278.73 - $327.27 $23,970 - $28,145
86 Added 3.84%
2,324 $753,000
Q1 2022

Apr 04, 2022

SELL
$234.69 - $291.66 $938 - $1,166
-4 Reduced 0.18%
2,238 $641,000
Q4 2021

Jan 07, 2022

BUY
$224.85 - $279.04 $18,212 - $22,602
81 Added 3.75%
2,242 $619,000
Q3 2021

Oct 05, 2021

BUY
$221.6 - $272.71 $44,320 - $54,541
200 Added 10.2%
2,161 $499,000
Q2 2021

Jul 02, 2021

BUY
$180.55 - $233.54 $21,666 - $28,024
120 Added 6.52%
1,961 $450,000
Q4 2020

Jan 05, 2021

SELL
$130.46 - $172.63 $32,615 - $43,157
-250 Reduced 11.96%
1,841 $310,000
Q2 2020

Jul 01, 2020

SELL
$136.42 - $164.18 $13,641 - $16,418
-100 Reduced 4.56%
2,091 $343,000
Q1 2019

Apr 29, 2019

SELL
$111.31 - $131.02 $22,262 - $26,204
-200 Reduced 8.36%
2,191 $262,000
Q1 2018

May 11, 2018

SELL
$74.21 - $87.6 $3,710 - $4,380
-50 Reduced 2.05%
2,391 $184,000
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $4,097 - $4,394
-50 Reduced 2.01%
2,441 $206,000
Q2 2017

Aug 15, 2017

BUY
N/A
2,491
2,491 $202,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track M&R Capital Management Inc Portfolio

Follow M&R Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&R Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on M&R Capital Management Inc with notifications on news.